Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization

Virology

Volumn 294, Issue 2, 2002, Pages 342-353

  Zheng, Xin ^a,d   Schirmbeck, Reinhold ^b   Hilken, Gero ^a   Waters, Jennifer A ^c   Yang, Dongliang ^d   Reimann, Jörg ^b   Roggendorf, Michael ^a   Lu, Mengji ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; PLASMID DNA; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENETIC CODE; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATITIS VIRUS; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOREACTIVITY; MAMMAL CELL; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS MUTANT;

HEPADNAVIRIDAE; HEPATITIS B VIRUS; MAMMALIA; MARMOTA MONAX; WOODCHUCK HEPATITIS B VIRUS;

EID: 0036056874     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1338     Document Type: Article

References (51)

1. Antibody response to pre-S2 and hepatitis virus induced liver damage
2. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant
3. Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides
4. Anti-pre-S responses and viral clearance in chronic hepatitis B virus infection
5. The clinical significance of surface antigen variants of hepatitis B virus
6. Vaccine-induced escape mutant of hepatitis B virus
7. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library
8. Altered antigenicity of "a" determinant variants of hepatitis B virus
9. Surface antigenic determinants of mammalian "hepadnavirus" defined by group- and class-specific monoclonal antibodies
10. Nonoverlapping antigenic sites of woodchuck hepatitis virus surface antigen and their cross-reactivity with ground squirrel hepatitis virus and hepatitis B virus surface antigens
11. Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen
12. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization
13. DNA-mediated immunization to hepatitis B surface antigen, longevity of primary response and effect of boost
14. DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines
15. DNA vaccines
16. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides
17. Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus
18. Nucleotide sequence of a cloned woodchuck hepatitis virus genome, comparison with the hepatitis B virus sequence
19. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice
20. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype specific antibodies in chimpanzees
21. Complete nucleotide sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host
22. Characterization of unusual escape variants of hepatitis B virus isolated from hepatitis B surface antigen-negative subject
23. Large surface proteins of hepatitis B virus containing the pre-S sequence
24. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis
25. Antigenicity of reduced and alkylated Australia antigen
26. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays
27. Epitope associated with a synthetic hepatitis B surface antigen peptide
28. A synthetic peptide vaccine involving the product of the pres2 region of hepatitis B virus DNA, protective efficacy in chimpanzees
29. A novel hepatitis B virus variant in the sera of immunized children
30. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the naive envelope protein of Dane particles
31. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection
32. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model
33. Secretion and antigenicity of epatitis small envelope proteins lacking cyteines in the major antigenic region
34. DNA-mediated immunization to the hepatitis B surface antigen in mice, aspects of the humoral response mimic hepatitis B viral infection in humans
35. Location and chemical synthesis of pre-S gene coded immunodominant epitope of hepatitis B virus
36. A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa 144 of the envelope major protein
37. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen
38. The woodchuck, an animal model for hepatitis B virus infection in man
39. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
40. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen
41. Woodchuck and duck hepatitis B viruses
42. Antigenic cross-reactions between woodchuck hepatitis virus and human hepatitis B virus shown by immune electron microscopy
43. Variable protein composition of hepatitis B surface antigen from different donors
44. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients
45. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks
46. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B), a final report
47. The woodchuck model of hepatitis B virus infection
48. Purification of woodchuck hepatitis surface antigen using a monoclonal antibody raised against the antigen
49. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum
50. Serological relationship of woodchuck hepatitis virus to human hepatitis B virus
51. A novel hepatitis virus variant S 129 (Gln-Leu), lack of correlation between antigenicity and immunogenicity